People taking GLP-1 agonists like Ozempic can lose significant weight and experience reduced food cravings, with potential benefits reaching beyond weight loss to include heart health, sleep apnea, kidney disease, and more.
GLP-1 agonists, like semaglutide and tirzepatide, initially developed for diabetes, have now shown benefits for various health conditions beyond weight loss, such as heart issues, sleep apnea, liver disease, and potential therapeutic effects on fertility, Alzheimer's, colorectal cancer, alcohol overuse, and more.
Collection
[
|
...
]